Home > Healthcare > Medical Devices > Surgical Devices > Neurothrombectomy Devices Market

Neurothrombectomy Devices Market Size

Report ID: GMI7700
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Neurothrombectomy Devices Market Size

Neurothrombectomy Devices Market was valued at USD 659 million in 2023 and is anticipated to attain 7.3% CAGR from 2024 to 2032. Neurothrombectomy devices belong to the category of neurovascular devices, which is estimated to reach 7.5 billion by 2032, designed to mechanically remove blood clots from vessels within the central nervous system, serving a crucial role in the acute ischemic stroke management. The increasing global incidence of ischemic stroke is fueling demand for neurothrombectomy devices.

To get key market trends

Download Free Sample

Furthermore, continued investments in research and development by industry players stimulate the exploration of cutting-edge technologies and surgical techniques, thereby enhancing the efficacy and safety of neurothrombectomy procedures. These resulting innovations not only contribute to improved patient outcomes but also position the neurothrombectomy market for sustained growth in the dynamic landscape of neurological interventions.

Neurothrombectomy Devices Market Report Attributes
Report Attribute	Details
Base Year:	2023
Neurothrombectomy Devices Market Size in 2023:	USD 659 Million
Forecast Period:	2024 to 2032
Forecast Period 2024 to 2032 CAGR:	7.3%
2032 Value Projection:	USD 1.2 Billion
Historical Data for:	2018 to 2023
No. of Pages:	85
Tables, Charts & Figures:	150
Segments covered:	Product Type, End-use, and Region
Growth Drivers:	Increasing prevalence of ischemic stroke Technological advancements in neurothrombectomy devices Increasing investments in research and development Rising awareness regarding neurological conditions
Pitfalls & Challenges:	High cost of devices Stringent regulatory scenario

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of neurorehabilitation devices was worth USD 1.9 billion in 2023 and is estimated to reach USD 5.8 billion by 2032, as they are designed to aid in the rehabilitation and recovery of individuals with neurological disorders or injuries.

The neurorobotics segment of neurorehabilitation devices industry garnered USD 604 million in 2023 and will grow significantly through 2032, as these devices enable intensive and repetitive training, promoting neuroplasticity and functional recovery.

The U.S. neurorehabilitation devices market accounted for USD 693 million in 2023 and is predicted to witness substantial growth through 2032, attributed to the country's advanced healthcare infrastructure, a robust R&D landscape, and a high prevalence of neurological disorders.

Bioventus LLC, Ectron Ltd., Hocoma (DIH Medical), BIOMETRICS LTD., Bionik Laboratories Corp., BioXtreme Ltd., Ekso bionics holdings, Inc., Kinestica, Saebo, Inc., Abbott Laboratories, Emotiv Inc., BrainCo, Inc, Permobil AB, and Medtronic Plc.